Nitric oxide modulates vascular disease in the remnant kidney model

American Journal of Pathology

Volumn 161, Issue 1, 2002, Pages 239-248

  Kang, D H ^b,c   Nakagawa, Takahiko ^a   Feng, Lili ^a   Johnson, R J ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Ewha Womans University   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME INHIBITION; GLOMERULOSCLEROSIS; HYPERPLASIA; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE EPITHELIUM; MALE; MICROVASCULATURE; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

EID: 0036310225     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64175-2     Document Type: Article

References (33)

1. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney
2. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant kidney model
3. Impaired angiogenesis in the remnant kidney model (I): Potential role of vascular endothelial growth factor and thrombospondin-1
4. Impaired angiogenesis in the remnant kidney model (II): VEGF administration reduces renal fibrosis and stabilizes renal function
5. Progressive renal disease: The chronic hypoxia hypothesis
6. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy
7. Chronic nitric oxide inhibition model six years on
8. Nitric oxide in renal health and disease
9. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model
10. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations
11. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition
12. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
13. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
14. Nitric oxide synthase inhibition by N(G)-nitro-Larginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors
15. A protective role of nitric oxide in a model of thrombotic microangiopathy in rats
16. Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease
17. The vascular pole of the renal glomerulus of rat
18. Physiology of renal hypoxia
19. ReIB regulation of chemokine expression modulates local inflammation
20. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis
21. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats
22. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure
23. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
24. Histologic studies of kidney biopsy specimens from patients with hypertension
25. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
26. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice: Role of endothelin
27. Preglomerular sudanophilia in L-NAME hypertensive rats: Involvement of endothelin
28. Renal hypertensive angiopathy: Comparison between chronic NO suppression and DOCA-salt intoxication
29. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
30. Role of endothelium in progressive renal disease
31. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
32. Renal and systemic nitric oxide synthesis in rats with renal mass reduction
33. Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure